Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
9.39M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
553K
-
Shares change
-
+15.5K
-
Total reported value, excl. options
-
$48.6M
-
Value change
-
+$1.39M
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$90.00
Significant Holders of Korro Bio, Inc. - Common stock, par value $0.001 per share (KRRO) as of Q1 2024
10 filings reported holding KRRO - Korro Bio, Inc. - Common stock, par value $0.001 per share as of Q1 2024.
Korro Bio, Inc. - Common stock, par value $0.001 per share (KRRO) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 553K shares
of 9.39M outstanding shares and own 5.89% of the company stock.
Largest 10 shareholders include CITADEL ADVISORS LLC (529K shares), JPMORGAN CHASE & CO (13.2K shares), MORGAN STANLEY (7.67K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (3.15K shares), Royal Bank of Canada (97 shares), CWM, LLC (6 shares), Kelly Financial Services LLC (1 shares), GROUP ONE TRADING, L.P. (0 shares), Orion Capital Management LLC (0 shares), and CITADEL ADVISORS LLC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.